Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer.
Moufarrij S, Srivastava A, Gomez S, Hadley M, Palmer E, Austin PT, Chisholm S, Diab N, Roche K, Yu A, Li J, Zhu W, Lopez-Acevedo M, Villagra A, Chiappinelli KB.
Moufarrij S, et al. Among authors: lopez acevedo m.
Sci Rep. 2020 Feb 26;10(1):3470. doi: 10.1038/s41598-020-60409-4.
Sci Rep. 2020.
PMID: 32103105
Free PMC article.